Company intelligence / Profile preview

NephroNet

Ownership: Private
Development stage: Other

Overview

NephroNet is an active consortium and clinical research organization specializing in nephrology. It connects academic and private clinical sites to advance care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The group supports pharmaceutical sponsors in drug development by facilitating site selection, study feasibility, trial execution, and educational initiatives such as CME/MOC programs. NephroNet is increasingly involved in the design and conduct of novel drug trials within the renal space.

Therapeutic areas: Nephrology
Industry: Contract Research Organization

Partnerships

Pharmaceutical sponsors of nephrology drug development (unspecified)

Beyond the preview

Go deeper on NephroNet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NephroNet.

Explore the full profile